Adalimumab Biosimilar Market: Growth, Key Players, and Trends 2032
The biosimilar market has been gaining momentum in recent years, particularly for high-value biologics like adalimumab. As patents for the originator product Humira expire, adalimumab biosimilars are becoming a focal point in the pharmaceutical industry, offering cost-effective alternatives to the world’s highest-grossing drug. In this blog, we’ll explore the key drivers of the adalimumab biosimilar…